BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33377727)

  • 1. [Enzyme activity of neuraminidase 1 correlated with the biological behavior of prostate cancer PC3 and DU145 cell lines].
    Wang MQ; Wang CX; Li S; Zhao W; Ma F; Ma X
    Zhonghua Nan Ke Xue; 2020 Aug; 26(8):681-685. PubMed ID: 33377727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of SOX10 on the proliferation and invasion of prostate cancer cells].
    Tang X; Zhao WH; Song QQ; Yin HQ; DU YQ; Sheng ZZ; Wang Q; Zhang XW; Li Q; Liu SJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):602-606. PubMed ID: 30122756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
    Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
    Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of SMAD4 in the mechanism of valproic acid's inhibitory effect on prostate cancer cell invasiveness.
    Jiang W; Zheng Y; Huang Z; Wang M; Zhang Y; Wang Z; Jin X; Xia Q
    Int Urol Nephrol; 2014 May; 46(5):941-6. PubMed ID: 24265041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
    Colella R; Jackson T; Goodwyn E
    Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
    Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
    BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
    Barrett CS; Millena AC; Khan SA
    Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway.
    Zhou X; Zhai Y; Liu C; Yang G; Guo J; Li G; Sun C; Qi X; Li X; Guan F
    Cell Commun Signal; 2020 Mar; 18(1):44. PubMed ID: 32164705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway.
    Ye J; Gao M; Guo X; Zhang H; Jiang F
    Biomed Pharmacother; 2020 Jul; 127():110223. PubMed ID: 32413672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
    Fu YM; Yu ZX; Li YQ; Ge X; Sanchez PJ; Fu X; Meadows GG
    Nutr Cancer; 2003; 45(1):60-73. PubMed ID: 12791506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
    Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
    Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sialidase NEU1 siRNA on proliferation, apoptosis, and invasion in human ovarian cancer.
    Ren LR; Zhang LP; Huang SY; Zhu YF; Li WJ; Fang SY; Shen L; Gao YL
    Mol Cell Biochem; 2016 Jan; 411(1-2):213-9. PubMed ID: 26463994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic α5 nicotinic receptor is involved in the proliferation and invasion of human prostate cancer cells.
    Qi JC; Xue WY; Zhang YP; Qu CB; Lu BS; Yin YW; Liu KL; Wang DB; Li W; Zhao ZM
    Oncol Rep; 2020 Jan; 43(1):159-168. PubMed ID: 31789411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2-deoxyglucose enhances chemosensitivity of androgen-independent prostate cancer cells to docetaxel].
    Zhou P; Lin YR; Huang MP; Xie KJ; Tang P
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3230-4. PubMed ID: 24405548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of leptin on leptin receptor isoform expression and proliferative activity in human normal prostate and prostate cancer cell lines.
    Szyszka M; Tyczewska M; Milecka P; Jopek K; Celichowski P; Malendowicz LK; Rucinski M
    Oncol Rep; 2018 Jan; 39(1):182-192. PubMed ID: 29115533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines.
    Colella R; Goodwyn E; Gopal P
    Cancer Lett; 2002 Nov; 185(2):163-72. PubMed ID: 12169390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity.
    Jayakumar S; Kunwar A; Sandur SK; Pandey BN; Chaubey RC
    Biochim Biophys Acta; 2014 Jan; 1840(1):485-94. PubMed ID: 24121106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity.
    Fiorentini C; Bodei S; Bedussi F; Fragni M; Bonini SA; Simeone C; Zani D; Berruti A; Missale C; Memo M; Spano P; Sigala S
    Exp Cell Res; 2014 Apr; 323(1):100-111. PubMed ID: 24589892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubimaillin suppresses proliferation, migration and invasion of prostate cancer cells via the Notch-1/MMP signaling pathway.
    Cai F; Guo S; Huang S; Li J; Liu W
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):130-134. PubMed ID: 32415939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.